nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Methimazole—Graves' disease	0.445	1	CbGbCtD
Pimecrolimus—MTOR—eye—Graves' disease	0.0526	0.129	CbGeAlD
Pimecrolimus—MTOR—connective tissue—Graves' disease	0.0507	0.124	CbGeAlD
Pimecrolimus—FKBP1A—eye—Graves' disease	0.0473	0.116	CbGeAlD
Pimecrolimus—FKBP1A—connective tissue—Graves' disease	0.0456	0.112	CbGeAlD
Pimecrolimus—MTOR—pituitary gland—Graves' disease	0.039	0.0957	CbGeAlD
Pimecrolimus—MTOR—adipose tissue—Graves' disease	0.0389	0.0953	CbGeAlD
Pimecrolimus—FKBP1A—pituitary gland—Graves' disease	0.0351	0.086	CbGeAlD
Pimecrolimus—FKBP1A—adipose tissue—Graves' disease	0.035	0.0857	CbGeAlD
Pimecrolimus—MTOR—thyroid gland—Graves' disease	0.0337	0.0825	CbGeAlD
Pimecrolimus—FKBP1A—thyroid gland—Graves' disease	0.0303	0.0742	CbGeAlD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.01	0.0683	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.0096	0.0655	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.00633	0.0432	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR3-mediated signaling events—CXCL10—Graves' disease	0.00569	0.0388	CbGpPWpGaD
Pimecrolimus—MTOR—TSH signaling pathway—TSHR—Graves' disease	0.00566	0.0386	CbGpPWpGaD
Pimecrolimus—MTOR—IL2 signaling events mediated by PI3K—IL2RA—Graves' disease	0.00444	0.0303	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—CXCL10—Graves' disease	0.00409	0.0279	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—CTLA4—Graves' disease	0.00394	0.0269	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—IFNG—Graves' disease	0.00385	0.0263	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—IL2RA—Graves' disease	0.00367	0.025	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—CD8A—Graves' disease	0.00335	0.0228	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—HLA-DQB1—Graves' disease	0.00324	0.0221	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—FASLG—Graves' disease	0.00315	0.0215	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL2RA—Graves' disease	0.00302	0.0206	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—HLA-A—Graves' disease	0.00298	0.0204	CbGpPWpGaD
Pimecrolimus—MTOR—Type II diabetes mellitus—TNF—Graves' disease	0.00288	0.0196	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.00281	0.0191	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—HLA-DRB1—Graves' disease	0.00273	0.0186	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—ICAM1—Graves' disease	0.00271	0.0185	CbGpPWpGaD
Pimecrolimus—MTOR—IFN-gamma pathway—IFNG—Graves' disease	0.0026	0.0177	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—Graves' disease	0.00249	0.017	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—HLA-DRB1—Graves' disease	0.00247	0.0168	CbGpPWpGaD
Pimecrolimus—MTOR—IFN-gamma pathway—IL1B—Graves' disease	0.00232	0.0158	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00222	0.0151	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00214	0.0146	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—HLA-DRB1—Graves' disease	0.00208	0.0142	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IFNG—Graves' disease	0.00206	0.0141	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—HLA-E—Graves' disease	0.00202	0.0138	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—IFNG—Graves' disease	0.00199	0.0136	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—CD4—Graves' disease	0.00192	0.0131	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—HLA-E—Graves' disease	0.0019	0.013	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL1B—Graves' disease	0.00184	0.0125	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—IFNG—Graves' disease	0.0018	0.0123	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL1B—Graves' disease	0.00178	0.0121	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—CD4—Graves' disease	0.00174	0.0119	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—IL1B—Graves' disease	0.00149	0.0101	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—CD4—Graves' disease	0.00147	0.01	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00138	0.00942	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—HLA-B—Graves' disease	0.00136	0.00924	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TNF—Graves' disease	0.00133	0.0091	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—Graves' disease	0.00127	0.00868	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—B3GNT2—Graves' disease	0.00115	0.00786	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—Graves' disease	0.00113	0.00774	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000984	0.00671	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IFIH1—Graves' disease	0.000939	0.00641	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000907	0.00619	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—HLA-E—Graves' disease	0.000739	0.00504	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-E—Graves' disease	0.00071	0.00484	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD40—Graves' disease	0.000694	0.00473	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CTLA4—Graves' disease	0.000684	0.00466	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TSHR—Graves' disease	0.000669	0.00456	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—B3GNT2—Graves' disease	0.000648	0.00442	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000563	0.00384	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFIH1—Graves' disease	0.000547	0.00373	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—HLA-B—Graves' disease	0.000527	0.00359	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD8A—Graves' disease	0.000526	0.00359	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-B—Graves' disease	0.000506	0.00345	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-A—Graves' disease	0.000469	0.0032	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HLA-A—Graves' disease	0.000467	0.00318	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL10—Graves' disease	0.000432	0.00295	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-E—Graves' disease	0.00043	0.00294	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000428	0.00292	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD40—Graves' disease	0.000421	0.00287	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTLA4—Graves' disease	0.000415	0.00283	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ICAM1—Graves' disease	0.000411	0.0028	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TSHR—Graves' disease	0.000376	0.00257	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQB1—Graves' disease	0.000341	0.00233	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2RA—Graves' disease	0.00033	0.00225	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD8A—Graves' disease	0.000319	0.00217	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD4—Graves' disease	0.000314	0.00214	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-B—Graves' disease	0.000307	0.00209	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD4—Graves' disease	0.000302	0.00206	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD4—Graves' disease	0.000301	0.00205	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2RA—Graves' disease	0.000287	0.00196	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-A—Graves' disease	0.000284	0.00194	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HLA-A—Graves' disease	0.000262	0.00179	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DRB1—Graves' disease	0.00026	0.00177	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICAM1—Graves' disease	0.000249	0.0017	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL10—Graves' disease	0.000243	0.00166	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GC—Graves' disease	0.00019	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFNG—Graves' disease	0.00019	0.00129	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2RA—Graves' disease	0.000186	0.00127	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD4—Graves' disease	0.000183	0.00125	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—Graves' disease	0.000169	0.00115	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD4—Graves' disease	0.000169	0.00115	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—B3GNT2—Graves' disease	0.000144	0.000982	CbGpPWpGaD
